LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering

Core Viewpoint - LeMaitre Vascular, Inc. plans to offer $150 million in Convertible Senior Notes due 2030 to qualified institutional buyers, with an option for initial purchasers to buy an additional $22.5 million in notes [1][2]. Group 1: Offering Details - The notes will be senior, unsecured obligations, accruing interest payable semi-annually, maturing on February 1, 2030, unless repurchased, redeemed, or converted earlier [2]. - Noteholders can convert their notes into cash, shares of common stock, or a combination thereof under certain conditions [2]. - The notes can be redeemed by LeMaitre starting February 5, 2028, if specific conditions regarding the stock price are met [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for working capital and general purposes, including potential acquisitions or investments in complementary companies, product lines, or technologies [3]. Group 3: Company Overview - LeMaitre Vascular, Inc. is a provider of devices, implants, and services for treating peripheral vascular disease, which affects over 200 million people globally [5].